Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seventeen research firms that are presently covering the stock, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 […]
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the company, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 […]
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seventeen ratings firms that are currently covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 1 year […]
Alnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 1-Year Low at $143.50 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com upgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a hold rating to a buy rating in a report issued on Friday morning. A number of other research firms have also issued reports on ALNY. Morgan Stanley reduced their price target on shares of Alnylam Pharmaceuticals from $184.00 to $176.00 and set an […]